US FDA Updates COVID-19 Vaccine Formulations, Revokes EUAs, ACIP Use Decision Next

Pathway in woods
Revocation of the EUAs means COVID-19 vaccines now will be marketed under a single pathway. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from United States